Insight Molecular Diagnostics Inc. Operating Lease Right-of-Use Assets
Insight Molecular Diagnostics Inc. (IMDX) had Operating Lease Right-of-Use Assets of $4.04 million as of 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2023-11-09
- 2023-09-30: Operating Lease, Right-of-Use Asset $4.04M.
- 2023-06-30: Operating Lease, Right-of-Use Asset $4.04M.
- 2023-03-31: Operating Lease, Right-of-Use Asset $3.50M.
- 2022-12-31: Operating Lease, Right-of-Use Asset $3.50M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2023-09-30 | $4.04M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $4.04M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $3.50M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $3.50M 10-Q · filed 2023-11-09 |
| 2022-09-30 | $3.50M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $3.50M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $3.50M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $3.50M 10-K · filed 2023-04-12 |
| 2021-09-30 | $3.50M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $3.40M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $3.40M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $3.40M 10-Q · filed 2021-11-09 |
| 2020-09-30 | $3.40M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $3.40M 10-Q · filed 2020-07-29 |
| 2020-03-31 | $3.39M 10-Q · filed 2020-05-12 |
| 2019-12-31 | $2.86M 10-K · filed 2021-03-19 |
| 2019-09-30 | $397.00K 10-Q · filed 2019-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |